BiotechTube
Home/Polaris Pharma/Samuel Chen
SC

Samuel Chen

Chairman & Chief Executive Officer

Polaris Pharma

Therapeutic Areas

OncologyMetabolic Disease

Polaris Pharma Pipeline

DrugIndicationPhase
ADI-PEG 20 (pegargiminase)Malignant Pleural Mesothelioma (Non-epithelioid)Phase 3 / BLA

Leadership Team at Polaris Pharma

JB
John Bomalaski, M.D.
Executive Vice President, Medical Affairs
AJ
Amanda Johnston, Ph.D.
Senior Vice President, Clinical Affairs
CH
Chris Huxsoll, Ph.D.
Senior Vice President, Operations
ML
Maureen Liu, MSc
Director, Clinical Development
View full Polaris Pharma profile